State LA
Clinical Trials in Louisiana
Recruiting clinical trials with at least one study location in Louisiana. Data updated daily from ClinicalTrials.gov.
Top Conditions in Louisiana
Malignant Solid Neoplasm (4)Lung Non-Small Cell Carcinoma (2)Melanoma (2)Non-Hodgkin Lymphoma (2)Chronic Lymphocytic Leukemia (2)Hidradenitis Suppurativa (2)Hematopoietic and Lymphatic System Neoplasm (2)Acute Myeloid Leukemia (2)Pressure Injury (2)Cardiovascular Diseases (2)Overweight (2)Obesity (2)
NCT07011459 N/A
Recruiting
The Cooking for Health Optimization and Disease Prevention (CHOP) Trial
Condition
Cardiovascular Diseases
Enrollment
96 pts
Location
United States
Sponsor
Tulane University
NCT04743141 Phase 3
Recruiting
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatme...
Condition
Acute Treatment of Migraine
Enrollment
600 pts
Location
United States, Poland, Spain
Sponsor
Pfizer
NCT06752668 Phase 2
Recruiting
A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
Condition
Narcolepsy Type 1
Enrollment
96 pts
Location
United States, Canada
Sponsor
Centessa Pharmaceuticals (UK)
NCT06356571 Phase 2
Recruiting
A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfil...
Condition
Plasma Cell Myeloma Refractory
Enrollment
64 pts
Location
United States
Sponsor
Sanofi
NCT06410209 Phase 2
Recruiting
A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervent...
Condition
Hematopoietic and Lymphatic System Neoplasm
Enrollment
190 pts
Location
United States, Puerto Rico
Sponsor
Children's Oncology Group
NCT06813911 Phase 3
Recruiting
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Partic...
Condition
Atherosclerotic Cardiovascular Disease (ASCVD)
Enrollment
340 pts
Location
United States, China, France
Sponsor
Novartis Pharmaceuticals
NCT07037433 Phase 3
Recruiting
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in P...
Condition
Atherosclerotic Cardiovascular Disease
Enrollment
12,800 pts
Location
United States, Argentina, Australia
Sponsor
Amgen
NCT07145229 Phase 2
Recruiting
Safety and Efficacy of ABP-745 in Participants With an Acute Gout Flare
Condition
Acute Gouty Arthritis
Enrollment
380 pts
Location
United States, Australia, China
Sponsor
Atom Therapeutics Co., Ltd
NCT04097145 N/A
Recruiting
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
Condition
Tricuspid Regurgitation
Enrollment
870 pts
Location
United States, Canada
Sponsor
Edwards Lifesciences
NCT07225946 Phase 3
Recruiting
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metas...
Condition
Prostatic Neoplasms, Castration-Resistant
Enrollment
800 pts
Location
United States, Australia, Brazil
Sponsor
Janssen Research & Development
NCT06972459 Phase 3
Recruiting
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight a...
Condition
Obesity
Enrollment
600 pts
Location
United States, Argentina, China
Sponsor
Eli Lilly and Company
NCT05327686 Phase 2
Recruiting
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for t...
Condition
Metastatic Renal Cell Carcinoma
Enrollment
240 pts
Location
United States, Australia, Canada
Sponsor
NRG Oncology
NCT05803941 Phase 4
Recruiting
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With ...
Condition
Prostate Cancer
Enrollment
700 pts
Location
United States, Austria, Belgium
Sponsor
Novartis Pharmaceuticals
NCT06624670 Phase 3
Recruiting
A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyo...
Condition
Pyoderma Gangrenosum
Enrollment
90 pts
Location
United States, Argentina, Australia
Sponsor
Boehringer Ingelheim
NCT07104383 Phase 3
Recruiting
VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)
Condition
Weight Loss
Enrollment
1,100 pts
Location
United States, Puerto Rico
Sponsor
Viking Therapeutics, Inc.
NCT06014502 Phase 1
Recruiting
Study to Evaluate IMGS-001 Treatment in Patients With Relapsed or Refractory Adv...
Condition
Solid Tumor
Enrollment
105 pts
Location
United States
Sponsor
ImmunoGenesis
NCT05580562 Phase 3
Recruiting
ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study...
Condition
H3 K27M
Enrollment
450 pts
Location
United States, Argentina, Australia
Sponsor
Jazz Pharmaceuticals
NCT05536141 Phase 1
Recruiting
A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Car...
Condition
Clear Cell Renal Cell Carcinoma
Enrollment
362 pts
Location
United States, Australia, South Korea
Sponsor
Arcus Biosciences, Inc.
NCT05966194 Phase 2
Recruiting
RRx-001 for Reducing Oral Mucositis in Patients Receiving Chemotherapy and Radia...
Condition
Oral Mucositis
Enrollment
216 pts
Location
United States
Sponsor
EpicentRx, Inc.
NCT05394467 N/A
Recruiting
Adipose Cellular Kinetics of Lipedema
Condition
Lipedema
Enrollment
24 pts
Location
United States
Sponsor
Pennington Biomedical Research
NCT05159466 N/A
Recruiting
Tulane Abdominal Transplant Institute (TATI) of Solid Organ Transplantation of H...
Condition
Human Immunodeficiency Virus
Enrollment
30 pts
Location
United States
Sponsor
Tulane University
NCT05855200 Phase 3
Recruiting
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage ...
Condition
Colonic Neoplasms
Enrollment
892 pts
Location
United States, Argentina, Australia
Sponsor
GlaxoSmithKline
NCT06662786 Phase 3
Recruiting
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or ...
Condition
Colorectal Neoplasms
Enrollment
1,000 pts
Location
United States, Belgium, Brazil
Sponsor
Janssen Research & Development
NCT06205186 N/A
Recruiting
Four Pillars of Defense: A Whole Health Approach to the Military
Condition
Health Behavior
Enrollment
400 pts
Location
United States
Sponsor
Pennington Biomedical Research
NCT02325674 N/A
Recruiting
MEASuRE: Metreleptin Effectiveness And Safety Registry
Condition
Generalised Lipodystrophy
Enrollment
100 pts
Location
United States, France, Germany
Sponsor
Amryt Pharma